Skip to content

A research model development that enables quantitative research to confirm the maintaining function of food's metabolic homeostasis for korean, the standardized Phenflex test is used to evaluate the changes in metabolic homeostasis of objects.

A research on human application to evaluate changes in metabolic homeostasis of Korean standard subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007842
Enrollment
120
Registered
2022-10-25
Start date
2022-11-21
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(standard Phenflex drink) : visit 1. Subjects who voluntarily sign the consent form for human application research will be judged for suitability according to the inclusion-exclusion criteria. v

Sponsors

Seoul National University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subject who voluntarily agrees to participate and sign in informed consent form 2) 19 to 70 years of age (male and female)

Exclusion criteria

Exclusion criteria: 1) following diseases - Having a history of gastrointestinal dysfunction, severe systemic disorder, abdominal surgery (excluding appendectomy and hernia surgery), or satellite type or intestinal resection - Liver dysfunction: ALT or AST 2.5 times or more of the upper limit of normal - Renal dysfunction: Subjects with less than eGFR 60. Subjects who have been diagnosed with acute kidney injury within 3 months of study registration. Subjects diagnosed with chronic kidney disease - Current clinically significant diabetes, hypertension, cholelithiasis, pancreatitis, gout, lung disease, gastrointestinal disease, gastrointestinal bleeding, history of gastrointestinal surgery, active tuberculosis, nervous system disease, mental disease, malignancy, musculoskeletal disease, and immune or inflammatory disease. - Having or having had a history of severe central nervous system disorders (depression, schizophrenia, epilepsy, alcoholism, drug addiction, eating disorders, etc.) requiring hospitalization or drug treatment - Having a history of allergic/hypersensitivity reactions - Thyroid disease, severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), heart disease (angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment). Even if there is no symptom, if there is a medical history, it can be excluded at the discretion of the investigator. 2) Consuming health functional food or prescription drugs within 1 month of their first visit 3) Subjects with irregular eating habits and lifestyle 4) Average alcohol consumption = 420g/week for men and = 210g/week for women 5) Smoker 6) Participate in a commercial obesity program or received calorie restriction diet treatment within 3 months of the first visit 7) Weight change of 10% or more within 3 months of their first visit 8) Regularly engage in high-intensity exercise (=10 hours/week) 9) Donate more than 500ml of blood within 3 months of their first visit 10) Participate in other clinical research within 1 month of the first visit and have received research drugs or health functional foods (except for cases where they have not taken drugs or health functional food) 11) Pregnant or lactating women 12) Judged by the researcher as inappropriate to participate in this research

Design outcomes

Primary

MeasureTime frame
Biochemical markers (glucagon, insulin, etc);Anthropometry & body composition

Secondary

MeasureTime frame
vital signs (pulse, blood pressure, body temperature)

Countries

Korea, Republic of

Contacts

Public Contactseon ha Jo

Seoul National University of Science and Technology

hs990310@naver.com+82-2-974-6740

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026